secwatch / observer
8-K filed May 2, 2023, 7:59 PM ET ticker ABT CIK 0000001800
other confidence high sentiment neutral materiality 0.15

Abbott shareholders elect all 12 director nominees, approve say-on-pay, reject four shareholder proposals

ABBOTT LABORATORIES

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ABBOTT LABORATORIES shareholders rejected Shareholder proposal requesting that Abbott’s Board of Directors adopt a policy that the Board Chairman be an independent director at the 2023-04-28 meeting.

Outcome
failed
Meeting
2023-04-28
Exact text from the filing
The shareholders rejected a shareholder proposal requesting that Abbott’s Board of Directors adopt a policy that the Board Chairman be an independent director, with 30.46 percent of the votes cast voting "For" the proposal.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ABBOTT LABORATORIES shareholders rejected Shareholder proposal that Abbott’s Board of Directors adopt a policy that no financial performance metric shall be adjusted to exclude legal or compliance costs when evaluating performance for the purpose of senior executive compensation at the 2023-04-28 meeting.

Outcome
failed
Meeting
2023-04-28
Exact text from the filing
The shareholders rejected a shareholder proposal that Abbott’s Board of Directors adopt a policy that no financial performance metric shall be adjusted to exclude legal or compliance costs when evaluating performance for the purpose of senior executive compensation, with 14.44 percent of the votes cast voting "For" the proposal.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ABBOTT LABORATORIES shareholders approved Election of Directors at the 2023-04-28 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-04-28
Exact text from the filing
The shareholders elected Abbott’s entire Board of Directors.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ABBOTT LABORATORIES shareholders rejected Shareholder proposal to lower the ownership threshold for calling special meetings of shareholders at the 2023-04-28 meeting.

Outcome
failed
Meeting
2023-04-28
Exact text from the filing
The shareholders rejected a shareholder proposal to lower the ownership threshold for calling special meetings of shareholders, with 4.26 percent of the votes cast voting "For" the proposal.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ABBOTT LABORATORIES shareholders approved Ratification of Ernst & Young LLP as Abbott’s auditors at the 2023-04-28 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-04-28
Exact text from the filing
The shareholders ratified the appointment of Ernst & Young LLP as Abbott’s auditors.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ABBOTT LABORATORIES shareholders approved Advisory vote on the frequency of future advisory votes on executive compensation at the 2023-04-28 meeting.

Proposal
say on pay frequency
Outcome
passed
Meeting
2023-04-28
Exact text from the filing
The shareholders voted to approve Abbott’s Board of Directors’ recommendation that Abbott present shareholders with the opportunity to vote on the compensation awarded to its named executive officers annually, with 97.86 percent of the votes cast voting "1 Year" for the proposal.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ABBOTT LABORATORIES shareholders rejected Shareholder proposal that Abbott’s Board of Directors prepare a report, to be updated annually, disclosing Abbott’s lobbying policies, procedures, and expenditures at the 2023-04-28 meeting.

Outcome
failed
Meeting
2023-04-28
Exact text from the filing
The shareholders rejected a shareholder proposal that Abbott’s Board of Directors prepare a report, to be updated annually, disclosing Abbott’s lobbying policies, procedures, and expenditures, with 22.97 percent of the votes cast voting "For" the proposal.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ABBOTT LABORATORIES shareholders approved Advisory vote to approve the compensation of Abbott’s named executive officers at the 2023-04-28 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-04-28
Exact text from the filing
The shareholders approved the compensation of Abbott’s named executive officers listed in the proxy statement for the Annual Meeting, with 90.01 percent of the votes cast voting "For" the proposal.
View on SEC.gov

Browse all shareholder votes →

ABBOTT LABORATORIES filing history →

Source: SEC EDGAR
accession 0001104659-23-054706
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.